Anna Maria Aschelter

Single-agent oxaliplatin in pretreated advanced breast cancer patients: A phase II study

Carlo Garufi, Cecilia Nisticò, S. Brienza et al. · Annals of Oncology · 2001 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients

Carlo Garufi, Barbara Vanni, Anna Maria Aschelter et al. · European Journal of Cancer · 2005 · 28 citations

Medicine, Oncology, Pharmacology +11

A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer

Carlo Garufi, Françis Lévi, Anna Maria Aschelter et al. · European Journal of Cancer · 1997 · 28 citations

Medicine, Oncology, Pharmacology +12

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience

Maurizio Valeriani, Luca Marinelli, Serena Macrini et al. · Radiation Oncology · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacology +16

Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients

Carlo Garufi, S. Brienza, Palma Pugliese et al. · Anti-Cancer Drugs · 2000 · 23 citations

Medicine, Oncology, Pharmacology +17